Sleep health company SleepScore Labs reported on Tuesday the completion of the acquisition of Sleep.ai and its wearable and digital app that detects snoring and bruxism.
Sleep.ai is a digital health company specialised in highly sophisticated analysis during sleep using a mobile device. The apps use special algorithms to filter and detect snoring. It offers a CE-certified app specialised in detecting teeth grinding during sleep. The app gives the option to track progress over time, and if needed, can recommend a local medical professional if the condition is of concern. Sleep.ai reportedly created an app and wearable for detecting if a user is snoring and/or grinding their teeth, known as bruxism and helps dentists monitor patients after they've begun dental treatment for either condition.
Additionally, the Sleep.ai app has been downloaded more than 250,000 times from the App Store and Google Play store and Sleep.ai apps will still be available on its own website as well as SleepScore Labs'.
Following closing, Sleep.ai's founder and CEO Michiel Allessie, a Dutch board-certified sleep dentist, will join the SleepScore Labs team in Carlsbad, Calif., as vice president of Snoring and Bruxism to continue advancing the latest technologies in detecting sleep issues.
The terms of the acquisition were not disclosed by the companies.
BD receives FDA clearance for Surgiphor 1000mL irrigation system
Galderma secures EU, US and Canada approval for new Restylane syringe
Organon licenses MIUDELLA IUD from Sebela Pharmaceuticals
Advita Ortho updates Chime clinical exchange application
Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems
Realheart secures European patent for artificial heart technology
Median Technologies secures FDA clearance for AI lung cancer screening software
Eli Lilly to invest over USD3.5bn in new Pennsylvania plant
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
Zylox-Tonbridge agrees staged acquisition of Germany's Optimed
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
Boston Scientific to acquire Valencia Technologies to expand overactive bladder portfolio
EQT Life Sciences exits Vivasure Medical in EUR185m sale to Haemonetics
Saluda Medical secures CE certification for EVA Sensing Technology in Europe